Junten Bio Co., Ltd.
PrivateLast Round
Convertible Debt
Oct 31, 2023
Total Funding Raised
$2.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Junten Bio Co., Ltd. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Convertible Debt round in October 2023.
Junten Bio Co., Ltd. is a biotechnology company that develops cell therapies to induce immune tolerance for organ transplant patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Junten Bio Co., Ltd. Comparables
Compare Junten Bio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quell Therapeutics | 84% | |
| Taiwan Bio Therapeutics Inc. | 81% | |
| RegCell, Inc. | 79% |
For institutional investors. Book with your work email.
Junten Bio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 31, 2023 | ||||
| Grant | Feb 1, 2022 | ||||
| VC Round | Dec 24, 2020 | ||||
| Seed | Jun 4, 2019 | ||||
| Seed | Dec 17, 2018 |
For institutional investors. Book with your work email.
Junten Bio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Shinsei Capital Partners | Seed |
| Mizuho Capital | Seed, Convertible Debt |
| 日本ベンチャーキャピタル株式会社 | Seed |
| Nissei Capital | Seed |
| Fujifilm Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 989% MoM.
- Oct 31, 2023
Mizuho Capital and Mizuho Bank led the round.
For institutional investors. Book with your work email.
Junten Bio Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Junten Bio Co., Ltd.'s valuation, stock price, and market status.
Is Junten Bio Co., Ltd. a public or private company?
Junten Bio Co., Ltd. is a private company.
What is the current stock price of Junten Bio Co., Ltd.?
Junten Bio Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Junten Bio Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Junten Bio Co., Ltd. worth (valuation)?
Valuation information for Junten Bio Co., Ltd. is not publicly available.
Can I buy Junten Bio Co., Ltd. stock?
Junten Bio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Junten Bio Co., Ltd.'s last funding round?
Junten Bio Co., Ltd.'s most recent funding round was Convertible Debt on October 31, 2023.
Who are the main investors in Junten Bio Co., Ltd.?
Key investors in Junten Bio Co., Ltd. include Mizuho Capital.
Will Junten Bio Co., Ltd. IPO soon?
No public IPO plans have been announced for Junten Bio Co., Ltd..
How can I track Junten Bio Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Junten Bio Co., Ltd.'s shares on secondary markets.